Merck & Co. Stock: Is Wall Street Bullish or Bearish?

With a market cap of $258 billion, Merck & Co., Inc. (MRK) is a global healthcare company, operating in the pharmaceutical and animal health sectors. Based in Rahway, New Jersey, Merck develops various human and animal health products, including blockbuster drugs like Keytruda and vaccines like Gardasil.

Shares of the pharmaceutical company have significantly underperformed the broader market over the past 52 weeks. MRK has declined 2.1% over this time, while the broader S&P 500 Index ($SPX) has rallied 31.3%. In 2024, shares of MRK are down 7.2%, compared to SPX’s nearly 20% gain on a YTD basis.